GlassScriptPhysician profile
William S Mckenzie
NPI 1346203387
$1,844.90
in general payments reported to CMS, 2019-2025
29 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $213 · 2021: $475 · 2022: $488 · 2023: $188 · 2024: $140 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.89 | 2019-2025 | |
| Astellas Pharma US INC | $195.43 | 2019-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $132.39 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Sumitomo Pharma America, INC. | $102.86 | 2023-2024 | Myfembree, Gemtesa |
| Duchesnay USA Incorporated | $95.68 | 2019 | |
| Amgen INC. | $82.60 | 2019-2022 | |
| Myovant Sciences INC. | $82.23 | 2021-2022 | |
| Channel Medsystems, INC. | $73.49 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.30 | 2019-2022 | |
| Urovant Sciences INC | $60.35 | 2021-2022 | |
| Minerva Surgical, INC | $51.91 | 2020-2021 | |
| Scynexis, INC. | $51.79 | 2021-2022 | |
| Coopersurgical, INC. | $50.03 | 2020-2021 | |
| Agile Therapeutics, INC. | $36.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.57 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $32.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organon LLC | $31.18 | 2022 | |
| Pfizer INC. | $30.38 | 2019-2023 | |
| Conmed Corporation | $28.20 | 2022-2023 | Visiclear, Airseal |
| Evofem Biosciences, INC. | $27.06 | 2021 | |
| Mayne Pharma Commercial LLC | $25.26 | 2022 | |
| Shield Therapeutics INC | $25.03 | 2024 | |
| Lupin INC. | $24.26 | 2020 | |
| Roche Diagnostics Corporation | $20.06 | 2020 | |
| Convatec INC. | $14.80 | 2022 | |
| Merck Sharp & Dohme LLC | $12.32 | 2021 | |
| Therapeuticsmd, INC. | $11.91 | 2022 | |
| Axonics, INC. | $11.85 | 2022 | |
| Covidien LP | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.